CFTR and cystic fibrosis: We further demonstrated that EMT is active in CF native tissues, primary cells, and CFTR-mutant cell lines, characterized by disrupted epithelial structure, defective junctions, increased mesenchymal markers and EMT-TFs, hyperproliferation, and impaired repair (Quaresma et al., 2020).